Patients with elevated levels of CTSS are more susceptible to DLBCL, which corresponds to a 20.6% increased hazard (odds ratio inverse variance weighted [ORIVW] = 1.206, 95% confidence interval [CI] 1.054–1.380, P = .006). Here, CTSS is linked to diffuse large B-cell lymphoma.